| Cover | Aug. 13, 2021 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Document Period End Date | Aug. 13, 2021 |
| Entity Registrant Name | Recursion Pharmaceuticals, Inc. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-40323 |
| Entity Tax Identification Number | 46-4099738 |
| Entity Address, Address Line One | 41 S Rio Grande Street |
| Entity Address, City or Town | Salt Lake City |
| Entity Address, State or Province | UT |
| Entity Address, Postal Zip Code | 84101 |
| City Area Code | 385 |
| Local Phone Number | 269 - 0203 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Class A Common Stock, par value $0.00001 per share |
| Trading Symbol | RXRX |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
| Entity Central Index Key | 0001601830 |
| Amendment Flag | false |
| Document Fiscal Year Focus | 2021 |
| Document Fiscal Period Focus | Q2 |
